Trinity Biotech (TRIB) Gains from Investment Securities (2021 - 2024)
Trinity Biotech's (TRIB) quarterly Gains from Investment Securities came in at -$233000.0 in Q4 2024, down 258.46% year-on-year from $147038.8 in Q1 2024, and down 258.46% quarter-over-quarter from -$65000.0 in Q4 2023.
Trinity Biotech (TRIB) Gains from Investment Securities (2021 - 2024) Analysis & Trends
Trinity Biotech has disclosed Gains from Investment Securities across 4 years of filings, most recently posting -$233000.0 for Q4 2024.
- Gains from Investment Securities for Q4 2024 came in at -$233000.0, down 258.46% year-over-year; the trailing twelve-month figure through Dec 2024 was $93000.0 (down 71.3% YoY), and the FY2024 annual result was $1.0 million, up 223.72% from the prior year.
- Gains from Investment Securities came in at -$233000.0 for Q4 2024 at Trinity Biotech, down from -$65000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $403000.0 in Q3 2023 to a low of -$233000.0 in Q4 2024.
- The 4-year median for Gains from Investment Securities is -$1036.0 (2021), against an average of $60742.6.
- Peak annual rise in Gains from Investment Securities reached 20250.0% in 2023, while the deepest fall reached 441.67% in 2023.
- Trinity Biotech's Gains from Investment Securities stood at $395000.0 in 2021, then plunged by 103.04% to -$12000.0 in 2022, then slumped by 441.67% to -$65000.0 in 2023, then sank by 258.46% to -$233000.0 in 2024.
- The last three Gains from Investment Securities figures came in at -$233000.0 (Q4 2024), -$65000.0 (Q4 2023), and $403000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -233,000.00 |
| Dec 31, 2024 | -233,000.00 |
| Dec 31, 2023 | -65,000.00 |
| Dec 31, 2023 | -65,000.00 |
| Sep 30, 2023 | 403,000.00 |
| Sep 30, 2023 | 403,000.00 |
| Dec 31, 2022 | -12,000.00 |
| Dec 31, 2022 | -12,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Jun 30, 2022 | 13.00 |
| Jun 30, 2022 | 13.00 |
| Dec 31, 2021 | 395,000.00 |
| Dec 31, 2021 | 395,000.00 |
| Jun 30, 2021 | -72.00 |
| Jun 30, 2021 | -72.00 |